What is JBIO's investment purchases?

JBIO (JBIO) reported investment purchases of $73.9M in Q1 2026.

What is the long-term trend for JBIO's investment purchases?

Over 2 years (2021 to 2023), JBIO's investment purchases has grown at a 4.6% compound annual growth rate (CAGR), from $113.25M to $123.98M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

JBIO JBIO Investment Purchases

Investment Purchases at other companies

Vertex PharmaceuticalsVRTX

$2.51B+52.2%

AnaptysBio, Inc.ANAB

$0-100%

Cullinan Therapeutics, Inc.CGEM

$20.14M-84.0%

Viridian Therapeutics, Inc.VRDN

$91.32M+28.2%

AnnexonANNX

$5.94M-90.4%

Nektar TherapeuticsNKTR

$452.25M+1,714%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's investment purchases?: JBIO (JBIO) reported investment purchases of $73.9M in Q1 2026.
What is the long-term trend for JBIO's investment purchases?: Over 2 years (2021 to 2023), JBIO's investment purchases has grown at a 4.6% compound annual growth rate (CAGR), from $113.25M to $123.98M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.